Waters Q2 sales up 4% to $741M, non-GAAP EPS $2.80; lowers FY organic growth guide to 0.5-1.5%

WATERS CORP /DE/

2023-Q2 EPS reported $4.95 revenue$1,425,250,000

Pharmaceutical market sales down 4% organic CC; China sales declined high teens.
Industrial +11% organic CC; Academic & Government +21% organic CC.
Full-year 2023 organic CC growth guided 0.5-1.5% (vs. prior); Q3 organic CC growth seen -4% to -2%.
Wyatt acquisition contributed 2% to Q2 sales; full-year impact ~2.5%.
Gross margin expanded 230 bps; non-GAAP EPS $2.80 vs. $2.75 a year ago.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

WATERS CORP /DE/ reported the quarter ended July 1, 2023 results: revenue $741 million, EPS $2.55.

Period: the quarter ended July 1, 2023
Revenue: $741 million
EPS: $2.55
Result: reported results

Exact text from the filing

Waters Corporation (NYSE: WAT) today announced its financial results for the second quarter of 2023. Sales for the second quarter of 2023 were $741 million

View on SEC.gov

Browse all earnings releases →

WATERS CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-23-201110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.